Eisai begins submitting searching for approval for Alzheimer’s drug lecanemab in China
travellinglight/iStock through Getty Photos Eisai (OTCPK:ESALF) (OTCPK:ESALY) began submission of knowledge for a biologics license utility ...
Read moreTag: lecanemab
Get the latest news and follow the coverage of Financial News, Stocks, Analysis, Trading Updates and more from the top trusted sources.